Cutting-Edge Study on Machine-Assisted Autism Screening in Young Children
This important multicenter study will evaluate a machine-assisted system for early screening of autism spectrum disorder (ASD) in toddlers aged 1.5 to 2.5 years. The research team will assess how accurately this technology can identify ASD compared to standard diagnostic methods. The study will involve 1,000 children across four groups: those with ASD, global developmental delay (GDD), language disorder (LD), and typically developing (TD) children.
Early detection of autism is crucial because:
- Early intervention leads to better long-term outcomes
- Children can get support during critical developmental windows
- Families can access appropriate resources sooner
- It reduces the "diagnostic odyssey" many families experience
The study uses two well-established diagnostic tools as benchmarks: the Autism Diagnostic Observation Schedule (ADOS-2) and the Griffiths Developmental Scales-Chinese edition (GDS-C). These will help researchers determine if the machine-assisted system works as effectively as current gold-standard methods.
For families considering participation, here's what you should know:
- The study involves children between 18-30 months old
- Participation includes standard developmental assessments
- Children from all developmental backgrounds are needed
- The research may contribute to better screening tools for future generations
The exclusion criteria help ensure safety and proper grouping. Children with certain genetic conditions, neurological disorders, or significant medical histories won't be included. This helps researchers get clear results about how well the screening system works specifically for autism-related concerns.
This research is particularly significant because:
- Current wait times for autism evaluations can be months or years
- Many communities lack specialists trained in autism diagnosis
- Objective screening tools could reduce disparities in access to care
- Early screening could benefit children with various developmental differences
The study will run from June 2025 to June 2028 across multiple hospitals in China, led by the Children's Hospital of Fudan University. The collaboration between so many institutions means the results will reflect diverse populations, making any findings more broadly applicable.
For parents and caregivers, understanding these research efforts is valuable because:
- It shows the scientific community's commitment to improving early detection
- It demonstrates how technology might help solve current diagnostic challenges
- It highlights the importance of developmental monitoring in toddlerhood
- It may lead to more accessible screening options in pediatric settings
The study measures several important outcomes, including social behaviors like responding to names, following instructions, and joint attention. These are fundamental skills that parents often notice first when concerned about development. By comparing human observations with machine assessments, researchers hope to create tools that can reliably flag early signs of autism.
This research represents an exciting intersection of clinical expertise and technological innovation. While nothing replaces comprehensive evaluation by specialists, reliable screening tools could help identify children who need full assessments sooner. For families navigating developmental concerns, studies like this offer hope for more accessible, timely support in the future.
Upcoming Clinical Trials
-
NCT07826949Not yet recruitingGlioma | Brain Neoplasm | Recurrent High-Grade Gliomas
-
NCT07826962Not yet recruiting
-
NCT07826975Not yet recruiting
-
NCT07826988Not yet recruitingSickle Cell Disease | Vaso-occlusive Crisis
-
NCT07827001RecruitingBrain Cancer | CNS Cancer | Nervous System Cancer | Brain Cancer Metastatic
-
NCT07827027Not yet recruiting
-
NCT07827040RecruitingAdults | Low Vision Digital Assistance | Visual Impairments
-
NCT07827053Not yet recruitingPancreatic Ductal Adenocarcinoma (PDAC)
-
NCT07827066Not yet recruitingSmoking Cessation | AI Agent | Early-Stage Cancer
-
NCT07827131Not yet recruiting